By Josh White
Date: Tuesday 27 May 2025
(Sharecast News) - 4basebio reported strong progress for the year ended 31 December on Tuesday, with revenue doubling from DNA sales to £0.93m and key operational milestones achieved.
By Josh White
Date: Wednesday 02 Apr 2025
(Sharecast News) - 4basebio announced on Wednesday that it has received Good Manufacturing Practice (GMP) certification from the UK's Medicines and Healthcare Products Regulatory Agency for its DNA manufacturing facility in Cambridge, marking a key milestone in its development as a supplier of clinical-grade synthetic DNA.
By Josh White
Date: Friday 27 Sep 2024
(Sharecast News) - 4basebio, a biotechnology company specialising in synthetic DNA products and nucleic acid delivery platforms, reported revenue of over £0.3m for the six months ended 30 June on Friday.
Currency | UK Pounds |
Share Price | 1,110.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1,820.00 |
52 Week Low | 1,070.80 |
Volume | 1 |
Shares Issued | 15.50m |
Market Cap | £172.01m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
You are here: research